Interacting Drugs |
Fosphenytoin vs Brentuximab Vedotin |
Security Level |
|
Mechanism |
Brentuximab Vedotin: CYP3A4 Inducers (Strong) may decrease the serum concentration of Brentuximab Vedotin. Specifically, concentrations of the active monomethyl auristatin E (MMAE) component may be decreased. |
Management |
Monitor therapy |
Fosphenytoin vs Brentuximab Vedotin
Post Review about Fosphenytoin vs Brentuximab Vedotin Click here to cancel reply.
Other Interactions of Fosphenytoin
Other Interactions of Brentuximab Vedotin
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.